Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Kenneth MacLean to Trisomy

This is a "connection" page, showing publications Kenneth MacLean has written about Trisomy.

 
Connection Strength
 
 
 
0.233
 
  1. Aivazidis S, Coughlan CM, Rauniyar AK, Jiang H, Liggett LA, Maclean KN, Roede JR. The burden of trisomy 21 disrupts the proteostasis network in Down syndrome. PLoS One. 2017; 12(4):e0176307.
    View in: PubMed
    Score: 0.130
  2. P?rez-Mancera PA, Gonz?lez-Herrero I, Maclean K, Turner AM, Yip MY, S?nchez-Mart?n M, Garc?a JL, Robledo C, Flores T, Guti?rrez-Ad?n A, Pintado B, S?nchez-Garc?a I. SLUG (SNAI2) overexpression in embryonic development. Cytogenet Genome Res. 2006; 114(1):24-9.
    View in: PubMed
    Score: 0.059
  3. de Souza FM, Busquet N, Blatner M, Maclean KN, Restrepo D. Galantamine improves olfactory learning in the Ts65Dn mouse model of Down syndrome. Sci Rep. 2011; 1:137.
    View in: PubMed
    Score: 0.022
  4. Kern DS, Maclean KN, Jiang H, Synder EY, Sladek JR, Bjugstad KB. Neural stem cells reduce hippocampal tau and reelin accumulation in aged Ts65Dn Down syndrome mice. Cell Transplant. 2011; 20(3):371-9.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)